|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/5575 | |
| A61K 45/06 | |||
| A61P 17/02 | |||
| A61P 43/00 |
| (11) | Patento numeris | 3049088 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14824091.4 |
| Europos patento paraiškos padavimo data | 2014-09-26 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-03 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-02-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/IB2014/002746 |
| Data | 2014-09-26 |
| (87) | Numeris | WO 2015/044788 |
| Data | 2015-04-02 |
| (30) | Numeris | Data | Šalis |
| 201361960740 P | 2013-09-26 | US |
| (72) |
SCHERER, Warren J., US
|
| (73) |
Galderma S.A.,
World Trade Center Avenue Gratta-Paille 1,, 1000 Lausanne 30 Grey,
CH
|
| (54) | PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING |
| PROSTAGLANDIN F2ALPHA AND ANALOGUES THEREOF FOR TREATING ATROPHIC CUTANEOUS SCARRING |